GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Little Green Pharma Ltd (ASX:LGP) » Definitions » LT-Debt-to-Total-Asset

Little Green Pharma (ASX:LGP) LT-Debt-to-Total-Asset : 0.03 (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Little Green Pharma LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Little Green Pharma's long-term debt to total assests ratio for the quarter that ended in Sep. 2023 was 0.03.

Little Green Pharma's long-term debt to total assets ratio increased from Dec. 2021 (0.00) to Sep. 2023 (0.03). It may suggest that Little Green Pharma is progressively becoming more dependent on debt to grow their business.


Little Green Pharma LT-Debt-to-Total-Asset Historical Data

The historical data trend for Little Green Pharma's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Little Green Pharma LT-Debt-to-Total-Asset Chart

Little Green Pharma Annual Data
Trend Jun19 Jun20 Jun21 Mar23
LT-Debt-to-Total-Asset
- 0.09 0.01 0.05

Little Green Pharma Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Mar23 Sep23
LT-Debt-to-Total-Asset Get a 7-Day Free Trial 0.08 0.01 - 0.05 0.03

Little Green Pharma LT-Debt-to-Total-Asset Calculation

Little Green Pharma's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

LT Debt to Total Assets (A: Mar. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2023 )/Total Assets (A: Mar. 2023 )
=5.312/98.62
=0.05

Little Green Pharma's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

LT Debt to Total Assets (Q: Sep. 2023 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2023 )/Total Assets (Q: Sep. 2023 )
=3.046/92.909
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Little Green Pharma  (ASX:LGP) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Little Green Pharma LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Little Green Pharma's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Little Green Pharma (ASX:LGP) Business Description

Traded in Other Exchanges
N/A
Address
66 Kings Park Road, Level 2, Suite 2, West Perth, Perth, WA, AUS, 6005
Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). The company offers LGP-branded medicinal cannabis oil products in the Australian and European markets.

Little Green Pharma (ASX:LGP) Headlines

No Headlines